Reports
Sale
Europe Infertility Diagnostics Devices Market Size, Report: By Product: Equipment, Media & Consumables, Accessories; By Procedure: In Vitro Fertilization, Intracytoplasmic Sperm Injection, Artificial Insemination, Fertility Surgeries, Others; By Patient Type: Female, Male; By Type; By End User; Regional Analysis; Supplier Landscape; 2024-2032
Europe Infertility Diagnostics Devices Market Outlook
The global infertility diagnostics devices market size is expected to grow at a CAGR of 8.80%, with Europe holding a significant market share during the forecast period of 2024-2032. The market is driven by the prevalence of infertility among couples, fuelled by factors such as delayed parenthood, lifestyle changes, and environmental influences in the region.
Key Takeaways
- Owing to technological improvements in diagnostic tools, including better imaging systems, sperm analysis techniques, and devices with artificial intelligence and machine learning integrated, the Europe infertility diagnostics devices market value is experiencing substantial growth. These developments are increasing the accuracy and efficacy of infertility diagnosis.
- The market is changing in favor of non-invasive, more individualized diagnostic options. Due to their ease of use and privacy, in-home fertility test kits are becoming more and more popular; however, non-invasive procedures are increasingly being chosen for diagnosis.
- The rising incidence of infertility in Europe can be attributed to a combination of changing lifestyles, environmental variables, and postponed parenthood. There is a greater need for infertility diagnosis tools due to a growing understanding and acceptance of reproductive problems and the range of diagnostic choices. Favorable reimbursement rules and the increase of fertility services are supporting this trend and driving the market's expansion.
Europe Infertility Diagnostics Devices Market Analysis
Infertility diagnostic devices are the tools used to assess and pinpoint the root causes of infertility in people or couples struggling to conceive. These tools leverage a variety of technologies, which includes kits that measure hormone levels, sperm quality and imaging devices that examine reproductive organs. There is a growing need for efficient diagnostic tools to support family planning and conception attempts due to the increasing prevalence of infertility.
Europe infertility diagnostics devices market demand is driven by multiple reasons, such as changing lifestyles, environmental conditions, and postponed childbearing. Such factors contribute to a greater incidence of infertility. The precision and effectiveness of diagnosing infertility are being improved by technological developments in diagnostics, including enhanced imaging systems and sperm analysis methods. More couples are seeking infertility testing, which can be attributed to increased awareness of reproductive problems and available diagnostic alternatives.
With multiple technological advancements, there has been an increased influx of new products and technologies. As a result, Europe infertility diagnostics devices market share is likely to augment in the forecast period. In October 2023, Caerus Biotech, a subsidiary of GryNumber Health Group, revolutionized male fertility diagnostics with a cutting-edge technology. The company launched a new sperm diagnostic device, MiOXSYS (Male Infertility Sperm Oxidative System), intended to provide clinicians with a quick and easy solution to assess oxidative stress levels. By measuring oxidation reduction potential (ORP), it helps in diagnosing infertility. Their focus is on addressing complex fertility challenges, particularly by exploring understudied factors to enhance patient outcomes.
Europe infertility diagnostics devices market growth is also driven by an increasing incidence of artificial intelligence-based startups in region. With nearly 1 in 6 adults worldwide experiencing infertility, the global fertility services market is projected to increase exponentially in the forecast period. However, existing solutions remain underfunded and inaccessible due to high costs and limited availability. AI technology is stepping in to address this gap with notable startups like Manina MedTech, a Spain based startup with an innovative solution called SEEDCHRONY. It calculates the optimal time for embryo transfer, significantly improving in vitro fertilization success rates. Sonio, on the other hand, is leveraging artificial intelligence to automate ultrasound reporting for prenatal screening, ensuring healthier pregnancies, and expanding the market share.
Europe Infertility Diagnostics Devices Market Segmentation
The report offers a detailed analysis of the market based on the following segments:
| Market Breakup | Categories |
| Product | Equipment, Media and Consumables, Accessories |
| Procedure | In Vitro Fertilization, Intracytoplasmic Sperm Injection, Artificial Insemination, Fertility Surgeries, Others |
| Patient Type | Female, Male |
| Type | Sperm Separation Devices, Ovum Aspiration Pumps, Sperm Analyzer Systems, Micromanipulator Systems, Incubators, Cryosystems, Imaging Systems, Microscope, Others |
| End User | Hospitals and Surgical Clinics, Cryobanks, Research Institutes, Others |
| Countries | United Kingdom, Germany, France, Italy, Others |
Europe Infertility Diagnostics Devices Market: Competitor Landscape
The key features of the market report include patent analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Cook Group
- Vitrolife
- Thermo Fisher Scientific
- Hamilton Thorne LTD
- Esco Micro Pte Ltd
- Genea Limited
- IVFtech APS
- FIJIFILM Irvine Scientific
- The Baker Company INC
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product |
|
| Breakup by Procedure |
|
| Breakup by Patient Type |
|
| Breakup by Type |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Europe Infertility Diagnostics Devices Market Overview
3.1 Europe Infertility Diagnostics Devices Market Historical Value (2017-2023)
3.2 Europe Infertility Diagnostics Devices Market Forecast Value (2024-2032)
4 Europe Infertility Diagnostics Devices Market Landscape*
4.1 Europe Infertility Diagnostics Devices: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Europe Infertility Diagnostics Devices: Product Landscape
4.2.1 Analysis by Product
4.2.2 Analysis by Procedure
5 Europe Infertility Diagnostics Devices Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.2.1 Strengths
5.2.2 Weaknesses
5.2.3 Opportunities
5.2.4 Threats
5.3 Porter’s Five Forces Analysis
5.3.1 Bargaining Power of Suppliers
5.3.2 Bargaining Power of Buyers
5.3.3 Threat of New Entrants
5.3.4 Threat of Substitutes
5.3.5 Degree of Rivalry
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Europe Infertility Diagnostics Devices Market Segmentation (2017-2032)
6.1 Europe Infertility Diagnostics Devices Market (2017-2032) by Product
6.1.1 Market Overview
6.1.2 Equipment
6.1.3 Media & Consumables
6.1.4 Accessories
6.2 Europe Infertility Diagnostics Devices Market (2017-2032) by Procedure
6.2.1 Market Overview
6.2.2 In Vitro Fertilization
6.2.3 Intracytoplasmic Sperm Injection
6.2.4 Artificial Insemination
6.2.5 Fertility Surgeries
6.2.6 Others
6.3 Europe Infertility Diagnostics Devices Market (2017-2032) by Patient Type
6.3.1 Market Overview
6.3.2 Female
6.3.3 Male
6.4 Europe Infertility Diagnostics Devices Market (2017-2032) by Type
6.4.1 Market Overview
6.4.2 Sperm Separation Devices
6.4.3 Ovum Aspiration Pumps
6.4.4 Sperm Analyzer Systems
6.4.5 Micromanipulator Systems
6.4.6 Incubators
6.4.7 Cryosystems
6.4.8 Imaging Systems
6.4.9 Microscope
6.4.10 Others
6.5 Europe Infertility Diagnostics Devices Market (2017-2032) by End User
6.5.1 Market Overview
6.5.2 Hospitals & Surgical Clinics
6.5.3 Cryobanks
6.5.4 Research Institutes
6.5.5 Others
6.6 Europe Infertility Diagnostics Devices Market (2017-2032) by Countries
6.6.1 Market Overview
6.6.2 United Kingdom
6.6.3 Germany
6.6.4 France
6.6.5 Italy
6.6.6 Others
7 United Kingdom Infertility Diagnostics Devices Market (2017-2032)
7.1 United Kingdom Infertility Diagnostics Devices Market (2017-2032) by Product
7.1.1 Market Overview
7.1.2 Equipment
7.1.3 Media & Consumables
7.1.4 Accessories
7.2 United Kingdom Infertility Diagnostics Devices Market (2017-2032) by Procedure
7.2.1 Market Overview
7.2.2 In Vitro Fertilization
7.2.3 Intracytoplasmic Sperm Injection
7.2.4 Artificial Insemination
7.2.5 Fertility Surgeries
7.2.6 Others
7.3 United Kingdom Infertility Diagnostics Devices Market (2017-2032) by Patient Type
7.3.1 Market Overview
7.3.2 Female
7.3.3 Male
7.4 United Kingdom Infertility Diagnostics Devices Market (2017-2032) by Type
7.4.1 Market Overview
7.4.2 Sperm Separation Devices
7.4.3 Ovum Aspiration Pumps
7.4.4 Sperm Analyzer Systems
7.4.5 Micromanipulator Systems
7.4.6 Incubators
7.4.7 Cryosystems
7.4.8 Imaging Systems
7.4.9 Microscope
7.4.10 Others
7.5 United Kingdom Infertility Diagnostics Devices Market (2017-2032) by End User
7.5.1 Market Overview
7.5.2 Hospitals & Surgical Clinics
7.5.3 Cryobanks
7.5.4 Research Institutes
7.5.5 Others
8 Germany Infertility Diagnostics Devices Market (2017-2032)
8.1 Germany Infertility Diagnostics Devices Market (2017-2032) by Product
8.1.1 Market Overview
8.1.2 Equipment
8.1.3 Media & Consumables
8.1.4 Accessories
8.2 Germany Infertility Diagnostics Devices Market (2017-2032) by Procedure
8.2.1 Market Overview
8.2.2 In Vitro Fertilization
8.2.3 Intracytoplasmic Sperm Injection
8.2.4 Artificial Insemination
8.2.5 Fertility Surgeries
8.2.6 Others
8.3 Germany Infertility Diagnostics Devices Market (2017-2032) by Patient Type
8.3.1 Market Overview
8.3.2 Female
8.3.3 Male
8.4 Germany Infertility Diagnostics Devices Market (2017-2032) by Type
8.4.1 Market Overview
8.4.2 Sperm Separation Devices
8.4.3 Ovum Aspiration Pumps
8.4.4 Sperm Analyzer Systems
8.4.5 Micromanipulator Systems
8.4.6 Incubators
8.4.7 Cryosystems
8.4.8 Imaging Systems
8.4.9 Microscope
8.4.10 Others
8.5 Germany Infertility Diagnostics Devices Market (2017-2032) by End User
8.5.1 Market Overview
8.5.2 Hospitals & Surgical Clinics
8.5.3 Cryobanks
8.5.4 Research Institutes
8.5.5 Others
9 France Infertility Diagnostics Devices Market (2017-2032)
9.1 France Infertility Diagnostics Devices Market (2017-2032) by Product
9.1.1 Market Overview
9.1.2 Equipment
9.1.3 Media & Consumables
9.1.4 Accessories
9.2 France Infertility Diagnostics Devices Market (2017-2032) by Procedure
9.2.1 Market Overview
9.2.2 In Vitro Fertilization
9.2.3 Intracytoplasmic Sperm Injection
9.2.4 Artificial Insemination
9.2.5 Fertility Surgeries
9.2.6 Others
9.3 France Infertility Diagnostics Devices Market (2017-2032) by Patient Type
9.3.1 Market Overview
9.3.2 Female
9.3.3 Male
9.4 France Infertility Diagnostics Devices Market (2017-2032) by Type
9.4.1 Market Overview
9.4.2 Sperm Separation Devices
9.4.3 Ovum Aspiration Pumps
9.4.4 Sperm Analyzer Systems
9.4.5 Micromanipulator Systems
9.4.6 Incubators
9.4.7 Cryosystems
9.4.8 Imaging Systems
9.4.9 Microscope
9.4.10 Others
9.5 France Infertility Diagnostics Devices Market (2017-2032) by End User
9.5.1 Market Overview
9.5.2 Hospitals & Surgical Clinics
9.5.3 Cryobanks
9.5.4 Research Institutes
9.5.5 Others
10 Italy Infertility Diagnostics Devices Market (2017-2032)
10.1 Italy Infertility Diagnostics Devices Market (2017-2032) by Product
10.1.1 Market Overview
10.1.2 Equipment
10.1.3 Media & Consumables
10.1.4 Accessories
10.2 Italy Infertility Diagnostics Devices Market (2017-2032) by Procedure
10.2.1 Market Overview
10.2.2 In Vitro Fertilization
10.2.3 Intracytoplasmic Sperm Injection
10.2.4 Artificial Insemination
10.2.5 Fertility Surgeries
10.2.6 Others
10.3 Italy Infertility Diagnostics Devices Market (2017-2032) by Patient Type
10.3.1 Market Overview
10.3.2 Female
10.3.3 Male
10.4 Italy Infertility Diagnostics Devices Market (2017-2032) by Type
10.4.1 Market Overview
10.4.2 Sperm Separation Devices
10.4.3 Ovum Aspiration Pumps
10.4.4 Sperm Analyzer Systems
10.4.5 Micromanipulator Systems
10.4.6 Incubators
10.4.7 Cryosystems
10.4.8 Imaging Systems
10.4.9 Microscope
10.4.10 Others
10.5 Italy Infertility Diagnostics Devices Market (2017-2032) by End User
10.5.1 Market Overview
10.5.2 Hospitals & Surgical Clinics
10.5.3 Cryobanks
10.5.4 Research Institutes
10.5.5 Others
11 Regulatory Framework
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Funding and Investment Analysis
13.1 Analysis by Funding Instances
13.2 Analysis by Type of Funding
13.3 Analysis by Funding Amount
13.4 Analysis by Leading Players
13.5 Analysis by Leading Investors
13.6 Analysis by Geography
14 Partnership and Collaborations Analysis
14.1 Analysis by Partnership Instances
14.2 Analysis by Type of Partnership
14.3 Analysis by Leading Players
14.4 Analysis by Geography
15 Supplier Landscape
15.1 Market Share by Top 5 Companies
15.2 Cook Group
15.2.1 Financial Analysis
15.2.2 Product Portfolio
15.2.3 Demographic Reach and Achievements
15.2.4 Mergers and Acquisitions
15.2.5 Certifications
15.3 Vitrolife
15.3.1 Financial Analysis
15.3.2 Product Portfolio
15.3.3 Demographic Reach and Achievements
15.3.4 Mergers and Acquisitions
15.3.5 Certifications
15.4 Thermo Fisher Scientific
15.4.1 Financial Analysis
15.4.2 Product Portfolio
15.4.3 Demographic Reach and Achievements
15.4.4 Mergers and Acquisitions
15.4.5 Certifications
15.5 Hamilton Thorne LTD
15.5.1 Financial Analysis
15.5.2 Product Portfolio
15.5.3 Demographic Reach and Achievements
15.5.4 Mergers and Acquisitions
15.5.5 Certifications
15.6 Esco Micro Pte Ltd
15.6.1 Financial Analysis
15.6.2 Product Portfolio
15.6.3 Demographic Reach and Achievements
15.6.4 Mergers and Acquisitions
15.6.5 Certifications
15.7 Genea Limited
15.7.1 Financial Analysis
15.7.2 Product Portfolio
15.7.3 Demographic Reach and Achievements
15.7.4 Mergers and Acquisitions
15.7.5 Certifications
15.8 IVFtech APS
15.8.1 Financial Analysis
15.8.2 Product Portfolio
15.8.3 Demographic Reach and Achievements
15.8.4 Mergers and Acquisitions
15.8.5 Certifications
15.9 FIJIFILM Irvine Scientific
15.9.1 Financial Analysis
15.9.2 Product Portfolio
15.9.3 Demographic Reach and Achievements
15.9.4 Mergers and Acquisitions
15.9.5 Certifications
15.10 The Baker Company INC
15.10.1 Financial Analysis
15.10.2 Product Portfolio
15.10.3 Demographic Reach and Achievements
15.10.4 Mergers and Acquisitions
15.10.5 Certifications
16 Europe Infertility Diagnostics Device Market – Distribution Model (Additional Insight)
16.1 Overview
16.2 Potential Distributors
16.3 Key Parameters for Distribution Partner Assessment
17 Key Opinion Leaders (KOL) Insights (Additional Insight)
18 Company Competitiveness Analysis (Additional Insight)
18.1 Very Small Companies
18.2 Small Companies
18.3 Mid-Sized Companies
18.4 Large Companies
18.5 Very Large Companies
19 Payment Methods (Additional Insight)
19.1 Government Funded
19.2 Private Insurance
19.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
Key Questions Answered in the Report
The global infertility diagnostics market is anticipated to grow at a CAGR of 8.80% during the forecast period of 2024-2032, with Europe holding a significant market share. It is driven by increasing infertility rates due to factors such as delayed parenthood, lifestyle changes, and environmental factors.
Increasing technological advancements, awareness around infertility, and growing acceptance of assisted reproductive technologies are fueling the demand for the market.
Major market trends include increased efforts to improve precision and effectiveness by leveraging sophisticated technologies like artificial intelligence and machine learning. Rising popularity of personalized medicine, and telehealth services are also amongst the major market trends.
Based on the procedure, the market is segmented into in vitro fertilization, intracytoplasmic sperm injection, artificial insemination, fertility surgeries, and others.
Various types of infertility diagnostic devices available in the market are sperm separation devices, ovum aspiration pumps, sperm analyzer systems, micromanipulator systems, incubators, cryosystems, imaging systems, microscope, and others.
It includes both males as well as females.
By product, the market is divided into equipment, media and consumables, along with accessories, among others.
The market breakup by types includes sperm separation devices, ovum aspiration pumps, sperm analyzer systems, micromanipulator systems, incubators, cryosystems, imaging systems, microscope, and others.
End users include hospitals and surgical clinics, cryobanks, research institutes, and others.
The market segmentation by countries includes United Kingdom, Germany, France, Italy, Others.
The key players in the market are Cook Group, Vitrolife, Thermo Fisher Scientific, Hamilton Thorne LTD, Esco Micro Pte Ltd, Genea Limited, IVFtech APS, FIJIFILM Irvine Scientific, The Baker Company INC.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER